v3.25.1
Note 8 - Accrued Liabilities
3 Months Ended
Mar. 31, 2025
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

8.         Accrued Liabilities

 

Accrued liabilities consisted of the following (in thousands):

 

   

March 31, 2025

   

December 31, 2024

 

Clinical trial costs

  $ 1,384     $ 2,277  

Research and development services

    1,239       888  

Compensation

    341       1,060  

Professional services fees

    82       112  

Other

    7       10  

Total accrued liabilities

  $ 3,053     $ 4,347